Meetings between the Food and Drug Administration (FDA) and industry sponsors are critical to conducting effective and efficient drug development and bringing life-changing, innovative medicines to ...

Tom Stoll is Senior Director of Federal Government Affairs for Genentech handling patents, tax, trade and tariffs. Before joining Genentech, Tom served as Chief Counsel on the Judiciary Committee of ...

Don Ware, a Partner at Foley Hoag, has over 40 years’ experience representing leading biopharma manufacturers, research institutions, and universities in patent and inventorship disputes, licensing, ...

BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

How can smart policy secure America’s leadership in biotechnology? BIO President & CEO John F. Crowley outlined the path forward in Senate testimony and a joint op-ed with Sen. Todd Young (R-IN). (703 ...

Lack of vaccination is allowing a measles comeback. Also, a sickle cell advocate explains why speaking out matters. (637 words, 3 minutes, 11 seconds) Measles: Completely preventable but making a ...

Geoff is a seasoned life sciences litigator with a particular focus on pharmaceuticals, biotechnology and medical devices, including Hatch-Waxman cases, Biologics Price Competition and Innovation Act ...

Erin Foley is counsel and registered patent attorney who advises clients in the fields of gene editing, gene therapy, RNA medicines, monoclonal antibodies, CAR-T and stem cell therapies, vaccines, ...

Gautam Prakash is the Associate Vice President for Intellectual Property Policy and Advocacy at Eli Lilly and Company. In this role he advocates for a robust IP system that protects biopharmaceutical ...

A Senate hearing promotes legislation that would provide clarity on patents. Also: heroism and advocacy around arthritis. (670 words, 3 minutes, 21 seconds) Senators push fix for patent clarity to ...